428 related articles for article (PubMed ID: 37484296)
1. The protective roles of citrus flavonoids, naringenin, and naringin on endothelial cell dysfunction in diseases.
Adetunji JA; Fasae KD; Awe AI; Paimo OK; Adegoke AM; Akintunde JK; Sekhoacha MP
Heliyon; 2023 Jun; 9(6):e17166. PubMed ID: 37484296
[TBL] [Abstract][Full Text] [Related]
2. Naringenin and naringin in cardiovascular disease prevention: A preclinical review.
Heidary Moghaddam R; Samimi Z; Moradi SZ; Little PJ; Xu S; Farzaei MH
Eur J Pharmacol; 2020 Nov; 887():173535. PubMed ID: 32910944
[TBL] [Abstract][Full Text] [Related]
3. Naringin and Naringenin Polyphenols in Neurological Diseases: Understandings from a Therapeutic Viewpoint.
Emran TB; Islam F; Nath N; Sutradhar H; Das R; Mitra S; Alshahrani MM; Alhasaniah AH; Sharma R
Life (Basel); 2022 Dec; 13(1):. PubMed ID: 36676048
[TBL] [Abstract][Full Text] [Related]
4. Citrus flavonoids and adhesion molecules: Potential role in the management of atherosclerosis.
Ebrahimi F; Ghazimoradi MM; Fatima G; Bahramsoltani R
Heliyon; 2023 Nov; 9(11):e21849. PubMed ID: 38028000
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of citrus flavanones naringin and naringenin and their food sources on lipid metabolism: An update on bioavailability, pharmacokinetics, and mechanisms.
Yang Y; Trevethan M; Wang S; Zhao L
J Nutr Biochem; 2022 Jun; 104():108967. PubMed ID: 35189328
[TBL] [Abstract][Full Text] [Related]
6. Naringin and Naringenin: Their Mechanisms of Action and the Potential Anticancer Activities.
Stabrauskiene J; Kopustinskiene DM; Lazauskas R; Bernatoniene J
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884991
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices.
So FV; Guthrie N; Chambers AF; Moussa M; Carroll KK
Nutr Cancer; 1996; 26(2):167-81. PubMed ID: 8875554
[TBL] [Abstract][Full Text] [Related]
8. Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis
Zhang Q; Liu J; Duan H; Li R; Peng W; Wu C
J Adv Res; 2021 Dec; 34():43-63. PubMed ID: 35024180
[TBL] [Abstract][Full Text] [Related]
9. The fate of naringin in humans: a key to grapefruit juice-drug interactions?
Fuhr U; Kummert AL
Clin Pharmacol Ther; 1995 Oct; 58(4):365-73. PubMed ID: 7586927
[TBL] [Abstract][Full Text] [Related]
10. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity.
Benavente-García O; Castillo J
J Agric Food Chem; 2008 Aug; 56(15):6185-205. PubMed ID: 18593176
[TBL] [Abstract][Full Text] [Related]
11. Beneficial Effects of Citrus Flavonoids on Cardiovascular and Metabolic Health.
Mahmoud AM; Hernández Bautista RJ; Sandhu MA; Hussein OE
Oxid Med Cell Longev; 2019; 2019():5484138. PubMed ID: 30962863
[TBL] [Abstract][Full Text] [Related]
12. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
[TBL] [Abstract][Full Text] [Related]
13. Antioxidative, Metabolic and Vascular Medicinal Potentials of Natural Products in the Non-Edible Wastes of Fruits Belonging to the
Chukwuma CI
Plants (Basel); 2024 Jan; 13(2):. PubMed ID: 38256745
[TBL] [Abstract][Full Text] [Related]
14. Meticulous parade on naringin respecting its pharmacological activities and novel formulations.
Alam M; Ahsan F; Mahmood T; Shamim A; Parveen S; Shariq M; Ansari VA
Avicenna J Phytomed; 2022; 12(5):457-474. PubMed ID: 36249455
[TBL] [Abstract][Full Text] [Related]
15. Biochemical changes and antioxidant capacity of naringin and naringenin against malathion toxicity in Saccharomyces cerevisiae.
Gerçek E; Zengin H; Erdem Erişir F; Yılmaz Ö
Comp Biochem Physiol C Toxicol Pharmacol; 2021 Mar; 241():108969. PubMed ID: 33412300
[TBL] [Abstract][Full Text] [Related]
16. Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits.
Lee CH; Jeong TS; Choi YK; Hyun BH; Oh GT; Kim EH; Kim JR; Han JI; Bok SH
Biochem Biophys Res Commun; 2001 Jun; 284(3):681-8. PubMed ID: 11396955
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive review on naringenin and naringin polyphenols as a potent anticancer agent.
Rauf A; Shariati MA; Imran M; Bashir K; Khan SA; Mitra S; Emran TB; Badalova K; Uddin MS; Mubarak MS; Aljohani ASM; Alhumaydhi FA; Derkho M; Korpayev S; Zengin G
Environ Sci Pollut Res Int; 2022 May; 29(21):31025-31041. PubMed ID: 35119637
[TBL] [Abstract][Full Text] [Related]
18. Inhibition characteristics and mechanism of tyrosinase using five citrus flavonoids: A spectroscopic and molecular dynamics simulation study.
Li W; Tian H; Guo F; Wu Y
J Food Biochem; 2022 Dec; 46(12):e14484. PubMed ID: 36239431
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of oral carcinogenesis by citrus flavonoids.
Miller EG; Peacock JJ; Bourland TC; Taylor SE; Wright JM; Patil BS; Miller EG
Nutr Cancer; 2008; 60(1):69-74. PubMed ID: 18444138
[TBL] [Abstract][Full Text] [Related]
20. Naringin, the major grapefruit flavonoid, specifically affects atherosclerosis development in diet-induced hypercholesterolemia in mice.
Chanet A; Milenkovic D; Deval C; Potier M; Constans J; Mazur A; Bennetau-Pelissero C; Morand C; Bérard AM
J Nutr Biochem; 2012 May; 23(5):469-77. PubMed ID: 21684135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]